MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar. The group has an integrated R&D center for both API and formulation under one roof, dedicated to research and development of pharmaceuticals to make them more accessible. With core focus on speed and consistency in delivery, MSN has achieved the following: ·More than 650 national and international patents ·Product portfolio featuring over 350 + APIs ·250+ Formulations, covering over 35 major therapies ·Won the trust of more than 40,000,000 customers across 65 countries globally